 |
Home | Site Map | Subscribe to our RSS Feed  |
 |
 |
snakemarket.com |
 |
|
Global Clinical Chemistry Analyzers and Reagents Market to Reach $5.7 Billion by 2012, According to New Report by Global Industry Analysts
San Jose, CA (PRWEB) November 5, 2008 -- Developments in clinical diagnostics market have historically been technology driven, powered by innovations in detection technologies, introduction of computerized systems and unearthing of new biochemical markers that have enabled laboratories to produce high-volume test results. Clinical chemistry analyzers market continues to focus on technological enhancements to combat the pressure for simplifying workflow, enhancing quality and accuracy through introduction of automated and user-friendly systems. Automated analyzers are gaining ground in the market for clinical chemistry analyzers. Europe and United States account for more than 71% of the global Clinical Chemistry Analyzers and Reagents market (http://www.strategyr.com/Clinical_Chemistry_Analyzers_and_Reagents_Market_Report.asp), as stated by the recent report published by Global Industry Analysts, Inc. Asia-Pacific is projected to register the fastest CAGR of 3.6% for the period 2011-2015. There is a growing demand for equipments facilitating on the spot assessment of various tests being conducted. Sophisticated and higher capacity analyzers, which can combat workload pressures due to increased testing volumes will score the maximum gains in the marketplace.
Global sales of clinical chemistry analyzers and reagents remain heavily skewed towards clinical chemistry reagents (http://www.strategyr.com/Clinical_Chemistry_Analyzers_and_Reagents_Market_Report.asp), which account for nearly two-thirds of the market's overall value estimated in 2008. The market is expected to benefit from the educated patient group, who proactively request tests, especially high-end tests for early diagnosis and better disease management. Although the market for clinical chemistry analyzers in developed nations is highly mature, growth mainly stems from low volume clinical chemistry analyzers that are mostly addressed to alternate site. In the United States, clinical chemistry analyzers market (http://www.strategyr.com/Clinical_Chemistry_Analyzers_and_Reagents_Market_Report.asp) is expected to reach US$700 million by 2012. In Europe, Germany and France account for 38% of the total clinical chemistry analyzers and reagents market.
Market for clinical laboratory instruments confronts challenges such as measuring up to latest technological developments, the commodity status of commonly ordered tests, and reimbursement limitations. To remain competitive and cost-effective many clinical laboratories tie up with diagnostic manufacturers over reagent rental contracts. Key players profiled in the study include Abbott Laboratories, Alfa Wassermann Inc., Beckman Coulter Inc, Cholestech Corporation, Hemagen Diagnostics Inc., Ortho-Clinical Diagnostics, Olympus America, Roche Diagnostics, Siemens Healthcare Diagnostics Inc, Sigma-Aldrich, and Sysmex Corporation, among others. Dominant players in the clinical laboratory analyzer market in the United States include Abbott Diagnostics, Roche Diagnostics, and Beckman Coulter.
The report, titled "Clinical Chemistry Analyzers and Reagents: A Global Strategic Business Report" published by Global Industry Analysts, Inc., covers major market dynamics, trends, issues, and competition pertaining to the market. The report traces key trends in the industry including increasing lab automation and development of integrated systems. Product segments covered include: Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) The report enumerates recent product launches, developments, mergers, acquisitions and other strategic industry activities. Analysis is presented for established and emerging markets including United States, Canada, Japan, France, Germany, United Kingdom, Italy, Asia-Pacific, and Latin America.
For more details of this research report please visit http://www.strategyr.com/Clinical_Chemistry_Analyzers_and_Reagents_Market_Report.asp
About Global Industry Analysts, Inc. Global Industry Analysts, Inc., (GIA) (http://www.StrategyR.com/) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc. Telephone 408-528-9966 Fax 408-528-9977 Email press @ StrategyR.com Web Site http://www.StrategyR.com/
###
This press release has been reprinted from PRWEB per the terms and conditions of the copyright notice.
Comment on "Global Clinical Chemistry Analyzers and Reagents Market to Reach $5.7 Billion by 2012, According to New Report by Global Industry Analysts" |
|
